EGFR and non-small cell lung carcinoma: Another study examined PD-L1 in 130 consecutive NSCLC samples and found that PD-L1 expression (TPS≥1%) was significantly associated with wild-type EGFR, and ROS1 rearrangement was associated with high PD-L1 expression (19).